Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Adage Capital Management, L.P. reported a 5.56% stake in Fulcrum Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 12, 2025
Adage Capital Management, L.P. reported a 5.56% stake in Fulcrum Therapeutics, Inc., 3,000,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G).
- Stake
- 5.56%
- Shares
- 3,000,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 5.56% | 3,000,000 |
| Robert Atchinson | 5.56% | 3,000,000 |
| Phillip Gross | 5.56% | 3,000,000 |
Source
Related
- Fulcrum Therapeutics, Inc.
- Adage Capital Management, L.P.
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 13, 2025
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2025
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026